Friday, October 4, 2024 Process to Safely Clear Some People with Prior-reported Allergy to Receive Penicillin for STIs Creative layout featuring a vial, syringe, and bandage covered with interconnected blue lines to represent an algorithm. Credit: NIAID Penicillin, a preferred treatment for syphilis and gonorrhea, can be given to many people with previously reported low-risk penicillin allergies. An algorithm developed by researchers in the NIAID-funded STI Clinical Trials Group allows STI clinics to safely clear people with previously reported penicillin allergy for use of the antibiotic for STI treatment. Using the process, 67% of people who reported prior penicillin allergy could safely receive the antibiotic for treatment of gonorrhea or syphilis. The study was published in Clinical Infectious Diseases. Learn More National Institute of Allergy and Infectious Diseases  |  National Institutes of Health

---

Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. Your subscription may be removed if you do not open our emails for a six-month period. 

This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).

                           

---

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107